about
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Ico...
Read More
169.19
-12.31
(-6.78%)
1.6M
XNAS Volume
XNAS 31 Jul, 2025 4:10 PM (EDT)
High Financial Strength
Mid Valuation
Technically Neutral
Mid-range Performer
These stocks are with strong quality. Their reasonable financials and technical aspects successfully gather investor's interest.
View Similar
Embed DVM
Icon Plc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..